AmCham Shanghai's Healthcare Committee invites you to a special breakfast briefing by The Economist Intelligence Unit followed by a industry panel discussion on Wednesday, June 29 from 08:30-10:30 at the Portman Ritz-Carlton Hotel.
Please join Ivy Teh, Managing Director, EIU Healthcare & Clearstate for a presentation of their latest research report on 'Understanding China's Emerging Private Healthcare Market'. She will be joined by panelists across key segments of the healthcare industry landscape including Clancey Houston, CEO, Chinaco Healthcare Corporation and David Basmajian, Head of Policy, Baxter Healthcare.
Attend this breakfast seminar to learn more from senior healthcare experts about:
China's emerging private healthcare market.
Major trends that will alter this business environment over the next five years.
The gradual shift in the types of care and services on offer to the paying patient.
How local and foreign companies should rethink their business models.
Review ways in which companies can engage with healthcare stakeholders in order to navigate risk, benefit and opportunities
08:30 Registration & Breakfast
09:40 Panel Discussion
About the Speakers:
Ivy Teh, Global Managing Director, EIU Healthcare & Clearstate Managing Director. Ivy co-founded Clearstate and serves as its Managing Director, heading a team of 35 healthcare consultants across the region since 2006. Ivy has over 16 years of healthcare consulting experience across medical technology, pharmaceutical and healthcare services sectors in Asia-Pacific and emerging markets. Her areas of expertise include commercial and operational strategy development, business model evaluation and innovation, capabilities assessment, market entry and growth strategy, greenfield exploration and commercial due diligence.
Ivy holds an MBA from Schulich School of Business, York University (Canada) and BSc (Hons) in Medical Physics from McMaster University (Canada).
Clancey Houston, Chief Executive Officer, Chinaco Healthcare Corporation. For twenty years Ms. Houston has grown and led multi-national and integrated teams in building, promoting and protecting brands and businesses, particularly in the pharma and consumer health sectors, in the highly complex and issues-rich emerging markets of Asia Pacific. As CEO, Ms. Houston leads Chinaco Healthcare Corporation’S (CHC’s) China team in advancing CHC’s mission to improve the quality of healthcare services provided to the mainstream population in China through the acquisition and management of large general or mid-sized specialty hospitals.
She guides the ongoing development of CHC’s Shanghai-based Shared Services platform, and also serves as Chairman of the Board at CHC’s first facility, CHC International Hospital (CHCIH), a 1,000-bed general hospital (currently built out to 500 beds in Phase 1) located in Cixi City, Zhejiang Province; and at CHC’s second hospital, Zhenjiang Ruikang Hospital in Jiangsu Province. CHCIH is China’s first large-scale Sino-US joint venture general hospital.
David Basmajian is Head of Policy, Asia Pacific for Baxter International, a U.S. healthcare company. Working out of Baxter’s Shanghai AP office, David develops policy positions and lobbying and communication materials for outreach to key constituent targets with an emphasis on the practical business application of policy positions that may impact Baxter’s medication delivery, biotech and renal products, therapies and services.
Prior to joining Baxter, David was communications director at The American Chamber of Commerce in Shanghai and worked at a public affairs and political consulting firm in California developing integrated communication and electoral strategies for elected officials, government agencies and companies.
This event is brought to you by AmCham Shanghai’s Healthcare Committee. For more information on how you can get involved in AmCham Shanghai’s industry-specific Committees, please contact firstname.lastname@example.org
Please click ‘Read More’ to RSVP.